國芳集團(601086.SH):主營業務未發生重大變化
格隆匯4月14日丨國芳集團(601086.SH)公佈,公司股價短期升幅過大的風險已近10個交易日,公司股票價格累計升幅達100.87%,同期同花順交易平台零售指數(881158)累計升幅為9.10%,公司股票短期升幅嚴重高於同期行業指數。截至2025年4月14日收盤,公司股票收盤價為9.28元/股,市盈率為86.80倍,行業平均值為23.68倍,顯著高於同行業水平;公司股票換手率為8.62%,顯著高於日常換手率。敬請廣大投資者理性投資,注意投資風險。
目前公司股票波動嚴重異常,存在市場情緒過熱的情形,可能存在非理性炒作,交易風險極大,存在短期大幅下跌的風險。公司主營業務未發生重大變化,基本面亦未發生重大變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.